MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$185,610K
Net Income
-$18,377K
Net Profit Margin
-9.90%
EPS
-$0.31
Unit: Thousand (K) dollars
Revenue Breakdown
Glaucoma
Corneal Health
Revenue Breakdown
US
Non Us
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net sales
185,610
150,571
143,121
133,537
Cost of sales
34,016
33,339
31,771
28,831
Impairment of intangible asset
-
-
112,867
-
Gross profit
151,594
117,232
-1,517
104,706
Selling, general and administrative
116,060
92,943
94,700
82,999
Research and development
51,301
44,145
43,651
38,072
Acquired in-process research and development
1,500
-
-
-
Total operating expenses
168,861
137,088
138,351
121,071
Loss from operations
-17,267
-19,856
-139,868
-16,365
Interest income
2,279
2,431
2,512
2,552
Interest expense
1,459
1,125
1,146
1,175
Other (expense) income, net
-1,274
-749
-1,314
-1,009
Total non-operating (expense) income
-454
557
52
368
Loss before taxes
-17,721
-19,299
-139,816
-15,997
Income tax provision
656
484
-6,159
234
Net loss
-18,377
-19,783
-133,657
-16,231
Basic EPS
-0.31
-0.34
-2.324
-0.28
Diluted EPS
-0.31
-0.34
-2.324
-0.28
Basic Average Shares
58,818,000
58,022,000
57,520,000
57,398,000
Diluted Average Shares
58,818,000
58,022,000
57,520,000
57,398,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
US
$118,549K
Non Us
$36,631K
US
$28,190K
Non Us
$2,240K
Net loss
-$18,377K
(6.51%↑ Y/Y)
Glaucoma
$155,180K
Corneal Health
$30,430K
Loss before taxes
-$17,721K
(8.70%↑ Y/Y)
Income tax provision
$656K
(164.52%↑ Y/Y)
Net sales
$185,610K
(49.54%↑ Y/Y)
Loss from operations
-$17,267K
(23.90%↑ Y/Y)
Total non-operating
(expense) income
-$454K
(-113.84%↓ Y/Y)
Gross profit
$151,594K
(55.92%↑ Y/Y)
Interest income
$2,279K
(-11.46%↓ Y/Y)
Cost of sales
$34,016K
(26.47%↑ Y/Y)
Total operating
expenses
$168,861K
(40.82%↑ Y/Y)
Interest expense
$1,459K
(26.76%↑ Y/Y)
Other (expense)
income, net
-$1,274K
(-168.61%↓ Y/Y)
Selling, general and
administrative
$116,060K
(39.20%↑ Y/Y)
Research and development
$51,301K
(40.40%↑ Y/Y)
Acquired in-process
research and development
$1,500K
Buy us a coffee
GLAUKOS Corp (GKOS)
GLAUKOS Corp (GKOS)